In addition, we confirmed the reduced expression of LINC00261 and MEG3, which are thought to function as tumour-suppressive lincRNAs in pancreatic cancer, and especially in neuroendocrine neoplasms in the case of MEG3 [27,28,29,30,31]. This evidence concerns the gene MEG3 and familial pancreatic carcinoma.